Breakout Session 1

MDR/IVDR: Collaboration and Alliance Opportunities

The implementation of new regulations such as MDR impacts Medical Devices manufactures and their processes on several levels. Authorized representatives, importers, distributors and suppliers will also feel the effects. In this session, we address possible opportunities for collaboration amongst industrial partners, as well as the anticipated pain points - starting at the executive level of your company, startup or spinoff.

Take home message:
Collaboration and relationship management have practical effects in daily business but are also bring legal considerations with them. The participants share and benefit from experiences and advice regarding difficulties from across the industry.


  • Daniel Zimmerli, Walder Wyss AG


  • Hansjörg Riedwyl, ISS AG
  • Peter Studer, SWISS MEDTECH
  • Beat Lechmann, Synthes Produktions GmbH

Breakout Session 2

Innovation Support for Startups and SMEs in Switzerland

The main topic of this breakout session is:

    • Swiss Landscape CH to promote startups and SMEs

This breakout session will then continue with an overview and an examination of the following key aspects:

    • Support: needs, status and required action
    • Financing
    • Industrialization and Regulatory

Take home message:
Participants will obtain a broad understanding of the Swiss support landscape. Following the keynote lecture describing the national system, topics such as financing and industrialization will be specifically addressed.


  • Heiko Visarius, VISARTIS Healthcare GmbH

Breakout Session 3

How Swiss Medtech Companies Can Take Advantage of Social Media

Social Media is still perceived by some C-Level representatives of Medtech Companies as a children's waste of time. But numbers show how significant the impact of Social Media networks is on business worldwide. In this session, we will examine the chances and risks of participating - or not participating - in those platforms. We will learn from the successes and failures of leading pharma and agile medtech companies.

Take home message:
Learn to achieve more with less, as well as how to use Social Media Networks to the advantage of your medtech company.


  • Andy Tonazzi, konplan systemhaus ag

Breakout Session 4

Current Research Trends in Medical Technology and Biomaterials

In this session, leading international experts will report on recent trends and developments in academic research with clear potential to significantly influence patient care in the near future. The talks will focus on the potential offered by nanotechnology, innovative processes and novel biomaterials to create new treatment approaches with increasing therapeutic efficiency, specificity and precision, while reducing invasiveness at the same time.

Take home message:
Participants will gain an overview of cutting edge directions in academic research and the expectations regarding their influence on future patient care.


  • Erik Schkommodau, FHNW

Breakout Session 5

How can we utilize the benefits of digitalization in our value chain and still comply with regulatory requirements of the industry?

For many companies digitalization seems to be the new password for innovation. In particular, utilizing digital elements to transform a conservative business model into a forward-looking business model is a key success factor. It is conceivable that digitalization should help maintain a competitive market position and optimize the value chain at the same time. Ideally, digitalization offers benefits for both companies, and their customers. But how can we ensure compliance with all industry and regulatory requirements when we transform the business model?

Take home message:
A basic understanding of the needs and expectations regarding digitization for a wide range of stakeholders within the life science industry.


  • Mike Rymerson, Dental Wings Inc.
  • Stefan Meierhans, National Price Supervisor 
  • Max Schönholzer, Sanitas Group AG
  • Thomas Bachofner, Swisscom Health AG


  • Heinz Sommer, companytransfer AG

Breakout Session 6

GOING GLOBAL - It’s a jungle out there

This breakout session is targeted for small-to-medium medtech companies who would like to learn from colleagues and other industries, be inspired by different concepts, debate alternative approaches, and learn about the decision criteria and the associated challenges of entering into new markets.

Take home message:
Learn from entrepreneurs and their experiences in order to take the right decisions.


  • Daniel A. Berdat, Exactech Inc.


  • Martin Schmidt, Jossi AG
  • Eric Perucco, medbraintec AG
  • Marcel Scacchi, Marcs Group AG